Grifols SA (GRFS)
Grifols Market Cap : 5.605B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.057M |
| Akari Therapeutics Plc | 4.610M |
| DBV Technologies SA | 1.191B |
| Cellectis SA | 354.18M |
| Pharma Mar SA | 1.663B |
Market Cap Related Metrics
| PE Ratio | 12.22 |
| PS Ratio | 0.6582 |
| PEG Ratio | 0.0718 |
| Price to Book Value | 2.386 |
| Price to Free Cash Flow | 7.922 |
| Price | 8.24 |
| Earnings Yield | 8.18% |
| PEGY Ratio | 0.0718 |
| Operating PE Ratio | 3.957 |
| Normalized PE Ratio | 12.80 |